نتائج البحث - "Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores]"

1

Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder

المساهمون: Clinical Cognitive Neuropsychiatry Research Program (CCNP), Häge, Alexander, Banaschewski, Tobias, Inglis, Sarah K., Carucci, Sara, Danckaerts, Marina, Dittmann, Ralf W., Falissard, Bruno, Garas, Peter, Hollis, Chris, Konrad, Kerstin, Kovshoff, Hanna, Liddle, Elizabeth, McCarthy, Suzanne, Neubert, Antje, Sonuga-Barke, Edmund J. S., Zuddas, Alessandro, Institut Català de la Salut, [Buitelaar JK, Greven CU] Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands. Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands. [van de Loo-Neus GHH] Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands. [Hennissen L] Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands. [Hoekstra PJ] University of Groningen, University Medical Center Groningen, Department of Child and Adolescent Psychiatry & Accare Child Study Center, Groningen, Netherlands. [Nagy P] Vadaskert Child and Adolescent Psychiatric Hospital, Budapest, Hungary. Bethesda Children's Hospital, Budapest, Hungary. [Ramos-Quiroga A] Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: European Neuropsychopharmacology, 64, 63-71. ELSEVIER SCIENCE BV
European neuropsychopharmacology : ENP 64, 63-71 (2022). doi:10.1016/j.euroneuro.2022.09.001
Scientia
European Neuropsychopharmacology, 64, pp. 63-71
European Neuropsychopharmacology, 64, 63-71

مصطلحات موضوعية: acciones y usos químicos::acciones farmacológicas::usos terapéuticos::fármacos del sistema nervioso central::fármacos psicotrópicos [COMPUESTOS QUÍMICOS Y DROGAS], Psicofàrmacs - Efectes secundaris, Heart rate, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Pressió sanguínia, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Central Nervous System Agents::Psychotropic Drugs [CHEMICALS AND DRUGS], 150 000 MR Techniques in Brain Function, Mental Disorders::Neurodevelopmental Disorders::Attention Deficit and Disruptive Behavior Disorders::Attention Deficit Disorder with Hyperactivity [PSYCHIATRY AND PSYCHOLOGY], 130 000 Cognitive Neurology & Memory, Other subheadings::Other subheadings::/adverse effects [Other subheadings], ADHD, Pharmacology (medical), Biological Psychiatry, Left ventricular Mass, Pharmacology, Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7], Psychiatry and Mental health, Neurology, Echocardiography, Blood pressure, Methylphenidate, Trastorn per dèficit d'atenció amb hiperactivitat - Tractament, Neurology (clinical), trastornos mentales::trastornos del desarrollo neurológico::trastornos conductuales disruptivos y déficit de atención::trastornos de déficit de atención con hiperactividad [PSIQUIATRÍA Y PSICOLOGÍA]

وصف الملف: application/pdf; text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78e5d3e534d9d13f480bc0b3b25af1cTest
https://hdl.handle.net/11370/f1ae0914-d241-4273-b46d-1550ce249da9Test

2

Consejos para evitar los efectos del exceso de calor en personas vulnerables [cartell]

المساهمون: Departament de Salut

المصدر: Scientia

مصطلحات موضوعية: Calor - Efectes fisiològics - Prevenció, Calor - Mesures de seguretat, desastres::riesgo::amenazas::meteorología::ola de calor [SALUD PÚBLICA], Environment and Public Health::Environment::Meteorological Concepts::Atmosphere::Weather::Hot Temperature::Environment and Public Health::Environment::Meteorological Concepts::Atmosphere::Weather::Extreme Heat [HEALTH CARE], Other subheadings::Other subheadings::/adverse effects [Other subheadings], Disasters::Risk::Hazards::Meteorology::Heat Wave (Meteorology) [PUBLIC HEALTH], ambiente y salud pública::ambiente::conceptos meteorológicos::atmósfera::tiempo atmosférico::temperatura alta::ambiente y salud pública::ambiente::conceptos meteorológicos::atmósfera::tiempo atmosférico::calor extremo [ATENCIÓN DE SALUD], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3991::bb5320c7777b3f9543bd9f24cee0d8f1Test
https://hdl.handle.net/11351/9748Test

3

Pla operatiu per prevenir els efectes de la calor sobre la salut (POCS): estiu 2023

المساهمون: Departament de Salut

المصدر: Scientia

مصطلحات موضوعية: Calor - Efectes fisiològics - Prevenció, Other subheadings::Other subheadings::/prevention & control [Other subheadings], Otros calificadores::Otros calificadores::/prevención & control [Otros calificadores], Environment and Public Health::Environment::Meteorological Concepts::Atmosphere::Weather::Hot Temperature::Environment and Public Health::Environment::Meteorological Concepts::Atmosphere::Weather::Extreme Heat [HEALTH CARE], Other subheadings::Other subheadings::/adverse effects [Other subheadings], salud ambiental::ciencia::meteorología::efectos del clima [SALUD PÚBLICA], Environmental Health::Science::Meteorology::Climate Effects [PUBLIC HEALTH], ambiente y salud pública::ambiente::conceptos meteorológicos::atmósfera::tiempo atmosférico::temperatura alta::ambiente y salud pública::ambiente::conceptos meteorológicos::atmósfera::tiempo atmosférico::calor extremo [ATENCIÓN DE SALUD], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Home - Influència del clima - Prevenció

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3991::322d5ea2f9786a8340717b14baa3d351Test
https://hdl.handle.net/11351/9856Test

4

Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Chlamydia trachomatis Isolates from Patients with Persistent or Clinical Treatment Failure in Spain

المؤلفون: Laura Villa, José Antonio Boga, Luis Otero, Fernando Vazquez, Ana Milagro, Paula Salmerón, Martí Vall-Mayans, María Dolores Maciá, Samuel Bernal, Luis Piñeiro

المساهمون: Institut Català de la Salut, [Villa L] Microbiology Department, Central University Hospital of Asturias and Health Research Institute of Asturias (ISPA), Oviedo, Spain. Sexually Transmitted Infections Study Group of the Infectious Diseases and Clinical Microbiology Spanish Society (GEITS-SEIMC), Madrid, Spain. [Boga JA] Microbiology Department, Central University Hospital of Asturias and Health Research Institute of Asturias (ISPA), Oviedo, Spain. [Otero L] Sexually Transmitted Infections Study Group of the Infectious Diseases and Clinical Microbiology Spanish Society (GEITS-SEIMC), Madrid, Spain. Microbiology Department, Cabueñes University Hospital, and Health Research Institute of Asturias (ISPA), Gijón, Spain. [Vazquez F] Microbiology Department, Central University Hospital of Asturias and Health Research Institute of Asturias (ISPA), Oviedo, Spain. Sexually Transmitted Infections Study Group of the Infectious Diseases and Clinical Microbiology Spanish Society (GEITS-SEIMC), Madrid, Spain. Department of Functional Biology, Microbiology Area, Faculty of Medicine, University of Oviedo, Oviedo, Spain. [Milagro A] Sexually Transmitted Infections Study Group of the Infectious Diseases and Clinical Microbiology Spanish Society (GEITS-SEIMC), Madrid, Spain. Microbiology Department, Miguel Servet University Hospital, Zaragoza, Spain. [Salmerón P] Sexually Transmitted Infections Study Group of the Infectious Diseases and Clinical Microbiology Spanish Society (GEITS-SEIMC), Madrid, Spain. Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Vall-Mayans M] Sexually Transmitted Infections Study Group of the Infectious Diseases and Clinical Microbiology Spanish Society (GEITS-SEIMC), Madrid, Spain. Unitat d’Infeccions de Transmissió Sexual Drassanes-Vall d'Hebron Hospital Universitari, Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Antibiotics; Volume 12; Issue 6; Pages: 975

مصطلحات موضوعية: Microbiology (medical), Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents [CHEMICALS AND DRUGS], infecciones bacterianas y micosis::infección::enfermedades de transmisión sexual [ENFERMEDADES], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos [COMPUESTOS QUÍMICOS Y DROGAS], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Biochemistry, Microbiology, Malalties de transmissió sexual - Tractament, Infectious Diseases, Medicaments antiinfecciosos - Efectes secundaris, Other subheadings::Other subheadings::/adverse effects [Other subheadings], Bacterial Infections and Mycoses::Infection::Sexually Transmitted Diseases [DISEASES], Pharmacology (medical), General Pharmacology, Toxicology and Pharmaceutics, Chlamydia trachomatis, antimicrobial susceptibility, treatment failure, sexually transmitted infection

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d867b06892dce1328c04463b6c484bfeTest
https://hdl.handle.net/11351/9985Test

5

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

المؤلفون: Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres

المساهمون: Institut Català de la Salut, [Adès L] INSERM U944, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis and University of Paris, Paris, France. [Girshova L] Federal Almazov North-West Medical Research Centre, Saint-Petersburg, Russia. [Doronin VA] City Clinical Hospital 40, Moscow, Russia. [Díez-Campelo M] Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain. [Valcárcel D] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Kambhampati S] Sarah Cannon at Research Medical Center, Kansas City, MO, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::antimetabolitos::antimetabolitos antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], Antimetabolites, Antineoplastic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastic [CHEMICALS AND DRUGS], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Leukemia, Myelomonocytic, Chronic, neoplasias::neoplasias por tipo histológico::leucemia::leucemia mieloide::leucemia mielomonocítica crónica [ENFERMEDADES], Cyclopentanes, Hematology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Quimioteràpia combinada, Medicaments antineoplàstics - Efectes secundaris, Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Myeloid::Leukemia, Myelomonocytic, Chronic [DISEASES], Pyrimidines, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Leucèmia mieloide aguda - Tractament, Other subheadings::Other subheadings::/adverse effects [Other subheadings], Azacitidine, Humans, Drug Therapy, Combination

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8838e72608b49d5e2a82c322c09cf86Test
https://doi.org/10.1182/bloodadvances.2022007334Test

6

Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers

المؤلفون: Jaume Alijotas‐Reig, Victor García‐GImenez, Peter J. Velthuis, Frank B. Niessen, Tom S. Decates

المساهمون: Institut Català de la Salut, [Alijotas-Reig J] Unitat de Malalties Autoimmunes Sistèmiques, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [García-GImenez V] Europe Medical Centre, Barcelona, Spain. Sociedad Española de Medicina y Cirugía Cosmética, Barcelona, Spain. [Velthuis PJ, Decates TS] Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands. [Niessen FB] Department of Plastic Surgery, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands, Vall d'Hebron Barcelona Hospital Campus, Dermatology, Plastic, Reconstructive and Hand Surgery, AII - Inflammatory diseases, AMS - Tissue Function & Regeneration

المصدر: Scientia
Journal of Cosmetic Dermatology, 21(8), 3181-3187. Wiley-Blackwell Publishing Ltd
Alijotas-Reig, J, García-GImenez, V, Velthuis, P J, Niessen, F B & Decates, T S 2022, ' Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers : A case series of 20 patients ', Journal of Cosmetic Dermatology, vol. 21, no. 8, pp. 3181-3187 . https://doi.org/10.1111/jocd.15117Test
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

مصطلحات موضوعية: Inflammation, acciones y usos químicos::usos especializados de productos químicos::materiales biomédicos y dentales::rellenos dérmicos [COMPUESTOS QUÍMICOS Y DROGAS], Vaccines, COVID-19 Vaccines, Complex Mixtures::Biological Products::Vaccines [CHEMICALS AND DRUGS], SARS-CoV-2, Medicaments - Efectes secundaris, COVID-19, Soft tissue fillers, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Dermatology, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation [DISEASES], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Inflamació, Injections, SDG 3 - Good Health and Well-being, Dermal Fillers, Other subheadings::Other subheadings::/adverse effects [Other subheadings], afecciones patológicas, signos y síntomas::procesos patológicos::inflamación [ENFERMEDADES], virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Humans, Adverse reactions, Chemical Actions and Uses::Specialty Uses of Chemicals::Biomedical and Dental Materials::Dermal Fillers [CHEMICALS AND DRUGS], COVID-19 (Malaltia) - Vacunació, mezclas complejas::productos biológicos::vacunas [COMPUESTOS QUÍMICOS Y DROGAS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280fe2634d5ad5e20e0f2d84a4015741Test
https://pure.eur.nl/en/publications/f1a0a836-7451-418e-8a28-b908f503fa12Test

7

Dasatinib-induced chylothorax: a clinical laboratory’s perspective

المؤلفون: García Martínez, Rafael, Sanz Gea, Clara, Martin Riera, Victor, Guerra-Ruiz, Armando, Paciucci Barzanti, Rosanna, Ferrer Costa, Roser, Ramírez Serra, Clara

المساهمون: Institut Català de la Salut, [Martínez RJG] Clinical Analysis Department, Marqués de Valdecilla University Hospital, Santander, Spain. Evidence-Based Laboratory Medicine Commission, Spanish Society of Laboratory Medicine (SEQCML), Barcelona, Spain. [Gea CS, Martin-Riera V, Ruiz ARG, Barzanti RP, Ferrer-Costa R, Ramirez-Serra C] Grup de Recerca de Bioquímica Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], enfermedades respiratorias::enfermedades pleurales::quilotórax [ENFERMEDADES], Other subheadings::Other subheadings::/chemically induced [Other subheadings], Other subheadings::Other subheadings::/adverse effects [Other subheadings], Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], Proteïnes quinases - Inhibidors - Efectes secundaris, Respiratory Tract Diseases::Pleural Diseases::Chylothorax [DISEASES], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Embassament pleural, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3991::6195967669a2e1a957b9e627177d10e5Test
https://hdl.handle.net/11351/9488Test

8

Failure of early non-invasive ventilation in preterm infants with respiratory distress syndrome in current care practice in Spanish level-III neonatal intensive care units – a prospective observational study

المؤلفون: Boix Alonso, Héctor, Fernandez Garcia, Cristina, Serrano Martín, María del Mar, Arruza, Luis, Concheiro-Guisan, Ana, Gimeno, Ana

المساهمون: Institut Català de la Salut, [Boix H] Division of Neonatology, Hospital Universitario Dexeus, Barcelona, Spain. [Fernández C] Servei de Neonatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Serrano Martín MM] Division of Neonatology, Regional University Hospital of Malaga, Málaga, Spain. [Arruza L] Department of Neonatology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain. [Concheiro A] Department of Neonatology, Álvaro Cunqueiro University Hospital, Vigo, Spain. [Gimeno A] Division of Neonatology, University and Polytechnic Hospital La Fe, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pulmons - Malalties - Tractament, Therapeutics::Therapeutics::Emergency Treatment::Resuscitation::Therapeutics::Respiration, Artificial [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Other subheadings::Other subheadings::/adverse effects [Other subheadings], enfermedades respiratorias::enfermedades pulmonares::síndrome disneico respiratorio del recién nacido [ENFERMEDADES], Other subheadings::/therapy [Other subheadings], terapéutica::terapéutica::tratamiento de urgencia::resucitación::terapéutica::respiración artificial [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Respiració artificial - Complicacions, Otros calificadores::/terapia [Otros calificadores], Respiratory Tract Diseases::Lung Diseases::Respiratory Distress Syndrome, Newborn [DISEASES]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3991::b67cad6a13c67c3e2043b04facc52744Test
https://hdl.handle.net/11351/9276Test

9

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

المساهمون: Institut Català de la Salut, [Harding JJ] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Medicine, Weill Cornell Medical College, New York, NY, USA. [Piha-Paul SA] Department of Investigational Cancer Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. [Shah RH, Murphy JJ] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Kravis Center for Molecular Oncology, Sloan Kettering Institute, New York, NY, USA. [Cleary JM, Shapiro GI] Dana-Farber Cancer Institute, Boston, MA, USA. [Braña I] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Molecular Therapeutic Research Unit – UITM-La Caixa, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Multidisciplinary, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], General Physics and Astronomy, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Biliary Tract Neoplasms [DISEASES], General Chemistry, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS], General Biochemistry, Genetics and Molecular Biology, Tracte biliar - Càncer - Tractament, Other subheadings::Other subheadings::/adverse effects [Other subheadings], neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias del tracto biliar [ENFERMEDADES], Proteïnes quinases - Inhibidors - Efectes secundaris

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3ce1cac90aacd3db242652601aa70bTest
https://doi.org/10.1038/s41467-023-36399-yTest

10

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

المساهمون: Institut Català de la Salut, [Lin NU] Dana-Farber Cancer Institute, Boston, Massachusetts. [Murthy RK] MD Anderson Cancer Center, Houston, Texas. [Abramson V] Vanderbilt University Medical Center, Nashville, Tennessee. [Anders C] Duke Cancer Institute, Durham, North Carolina. [Bachelot T] Centre Léon Bérard, Lyon, France. [Bedard PL] University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. [Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
U. Lin, N, K. Murthy, R, Abramson, V, Anders, C, Bachelot, T, L. Bedard, P, Borges, V, Cameron, D A, A. Carey, L, Chien, J, Curigliano, G, P. Di Giovanna, M, Gelmon, K, Hortobagyi, G, A. Hurvitz, S, Krop, I, Loi, S, Loibl, S, Mueller, V, Oliveira, M, Paplomata, E, Pegram, M, Slamon, D, Zelnak, A, Ramos, J, Feng, W & Winer, E 2022, ' Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain MetastasesUpdated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2022.5610Test

مصطلحات موضوعية: Cancer Research, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], neoplasias::neoplasias por localización::neoplasias del sistema nervioso::neoplasias del sistema nervioso central::neoplasias cerebrales [ENFERMEDADES], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Quimioteràpia combinada, Medicaments antineoplàstics - Efectes secundaris, Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms::Brain Neoplasms [DISEASES], Oncology, Metàstasi, Cervell - Càncer - Tractament, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Mama - Càncer - Tractament, Other subheadings::Other subheadings::/adverse effects [Other subheadings]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f800399cc04de7baef3960b16afc0f9bTest
https://hdl.handle.net/11351/9527Test

تنقيح النتائج